1993JAMARequires access

Blood Donation by Patients With Hemochromatosis-Reply

Alfred J. Grindon

Open publisher page 4 citations

Abstract

In Reply. —As Dr Friedrich states, patients with hemochromatosis are quite capable of providing units of blood. However, the number of such patients in the United States is so few that they would provide only a minimal increase in available blood. I differ with him in his feeling that patients with hemochromatosis do not gain from blood donation. These patients currently incur significant cost and inconvenience in obtaining therapeutic phlebotomy services from hospitals, physicians' offices, or blood centers, and therefore may seek to be blood donors to avoid these costs, whether qualified or not. Finally, it is generally believed by regulating and accrediting agencies that laboratory procedures alone are insufficient to provide the required minimal risk of transfusion-transmitted disease. Dr Penning notes correctly that donor motivation is insufficient for product safety; however, it is a necessary element. As he points out, the practice of using this blood is allowed if

About this research paper

What this paper is about

In Reply. —As Dr Friedrich states, patients with hemochromatosis are quite capable of providing units of blood. However, the number of such patients in the United States is so few that they would provide only a minimal increase in available blood. I differ with him in his feeling that patients with hemochromatosis do not gain from blood donation. These patients currently incur significant cost and inconvenience in obtaining therapeutic phlebotomy services from hospitals, physicians' offices, or blood centers, and therefore may seek to be blood donors to avoid these costs, whether qualified or not. Finally, it is generally believed by regulating and accrediting agencies that laboratory procedures alone are insufficient to provide the required minimal risk of transfusion-transmitted disease. Dr Penning notes correctly that donor motivation is insufficient for product safety; however, it is a necessary element. As he points out, the practice of using this blood is allowed if

Why it matters

OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

In Reply. —As Dr Friedrich states, patients with hemochromatosis are quite capable of providing units of blood. However, the number of such patients in the United States is so few that they would provide only a minimal increase in available blood. I differ with him in his feeling that patients with hemochromatosis do not gain from blood donation. These patients currently incur significant cost and inconvenience in obtaining therapeutic phlebotomy services from hospitals, physicians' offices, or blood centers, and therefore may seek to be blood donors to avoid these costs, whether qualified or not. Finally, it is generally believed by regulating and accrediting agencies that laboratory procedures alone are insufficient to provide the required minimal risk of transfusion-transmitted disease. Dr Penning notes correctly that donor motivation is insufficient for product safety; however, it is a necessary element. As he points out, the practice of using this blood is allowed if

Key concepts: Phlebotomy, Medicine, Blood donor, Hemochromatosis, Donation, Feeling, Intensive care medicine, Blood transfusion

Related papers

Back to paper searchBrowse research topicsOriginal source
Blood Donation by Patients With Hemochromatosis-Reply — Research Paper | ScholarLens